Pub Date : 2025-04-10DOI: 10.1016/j.jpainsymman.2025.02.031
Kathryn Huber MD, Matthew DeCamp MD PhD, Ahmed Alasmar, Mika Hamer PhD MPH
<div><h3>Outcomes</h3><div>1. Participants will be able to comprehend the use of artificial intelligence-based prognostication as a form of “screening” for end-of-life.</div><div>2. Participants will be able to analyze the ethical challenges that could shape the implementation of artificial intelligence-based prognostication in palliative care and apply ethical principles that can help guide that implementation.</div></div><div><h3>Key Message</h3><div>Based on qualitative interviews at four U.S. medical centers, palliative care team members view artificial intelligence-based prognostication tools as a form of “screening” – so understood, the established ethics principles governing screening can yield concrete recommendations for the ethical use of these AI prognostic tools.</div></div><div><h3>Abstract</h3><div>Artificial Intelligence (AI) tools for healthcare applications are rapidly emerging, with some tools already being used and more on their way. One example is AI-based prognostication tools which can predict patient mortality automatically and with accuracy that outperforms clinicians and other available tools. In palliative care, prognostication may be particularly important; these tools may change practice in ways we do not fully understand and raise important ethical and implementation questions.</div></div><div><h3>Objective</h3><div>To identify the ethical challenges that could shape implementation of AI-based prognostication in palliative care.</div></div><div><h3>Methods</h3><div>We conducted semi-structured interviews with 45 palliative care physicians, nurses, and other team members from four academic medical centers. Interviews were transcribed and analyzed using grounded theory.</div></div><div><h3>Results</h3><div>A central theme emerged: implementation of AI-based prognostication was seen as a form of “screening” for end-of-life (EoL). While the idea of prognostication as screening for EoL is novel, the ethics of screening in other clinical contexts is well-established. For this reason, we drew on a model of screening ethics (1) as a framework for our analysis. Interpreting our interview data through this lens, we identified four principles to guide the implementation of AI-based prognostication as screening: (i) screening for EoL should be evidence based, (ii) screening for EoL should take opportunity cost into account, (iii) screening for EoL should distribute costs and benefits fairly, and (iv) screening for EoL should offer respect for persons and their dignity.</div></div><div><h3>Conclusion</h3><div>Our findings help us understand how palliative care team members view emerging AI-based prognostic tools and offer guiding principles for their implementation as screening for EoL. In the future, it will be important to define the role of screening in this context and to understand how the result of the screening affects decision-making for patients, families, and care teams.</div></div><div><h3>References</h3><div>1.Bailey M
{"title":"The Ethics of Artificial Intelligence-based Screening for End-of-life and Palliative Care","authors":"Kathryn Huber MD, Matthew DeCamp MD PhD, Ahmed Alasmar, Mika Hamer PhD MPH","doi":"10.1016/j.jpainsymman.2025.02.031","DOIUrl":"10.1016/j.jpainsymman.2025.02.031","url":null,"abstract":"<div><h3>Outcomes</h3><div>1. Participants will be able to comprehend the use of artificial intelligence-based prognostication as a form of “screening” for end-of-life.</div><div>2. Participants will be able to analyze the ethical challenges that could shape the implementation of artificial intelligence-based prognostication in palliative care and apply ethical principles that can help guide that implementation.</div></div><div><h3>Key Message</h3><div>Based on qualitative interviews at four U.S. medical centers, palliative care team members view artificial intelligence-based prognostication tools as a form of “screening” – so understood, the established ethics principles governing screening can yield concrete recommendations for the ethical use of these AI prognostic tools.</div></div><div><h3>Abstract</h3><div>Artificial Intelligence (AI) tools for healthcare applications are rapidly emerging, with some tools already being used and more on their way. One example is AI-based prognostication tools which can predict patient mortality automatically and with accuracy that outperforms clinicians and other available tools. In palliative care, prognostication may be particularly important; these tools may change practice in ways we do not fully understand and raise important ethical and implementation questions.</div></div><div><h3>Objective</h3><div>To identify the ethical challenges that could shape implementation of AI-based prognostication in palliative care.</div></div><div><h3>Methods</h3><div>We conducted semi-structured interviews with 45 palliative care physicians, nurses, and other team members from four academic medical centers. Interviews were transcribed and analyzed using grounded theory.</div></div><div><h3>Results</h3><div>A central theme emerged: implementation of AI-based prognostication was seen as a form of “screening” for end-of-life (EoL). While the idea of prognostication as screening for EoL is novel, the ethics of screening in other clinical contexts is well-established. For this reason, we drew on a model of screening ethics (1) as a framework for our analysis. Interpreting our interview data through this lens, we identified four principles to guide the implementation of AI-based prognostication as screening: (i) screening for EoL should be evidence based, (ii) screening for EoL should take opportunity cost into account, (iii) screening for EoL should distribute costs and benefits fairly, and (iv) screening for EoL should offer respect for persons and their dignity.</div></div><div><h3>Conclusion</h3><div>Our findings help us understand how palliative care team members view emerging AI-based prognostic tools and offer guiding principles for their implementation as screening for EoL. In the future, it will be important to define the role of screening in this context and to understand how the result of the screening affects decision-making for patients, families, and care teams.</div></div><div><h3>References</h3><div>1.Bailey M","PeriodicalId":16634,"journal":{"name":"Journal of pain and symptom management","volume":"69 5","pages":"Pages e425-e426"},"PeriodicalIF":3.2,"publicationDate":"2025-04-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143807047","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-04-10DOI: 10.1016/j.jpainsymman.2025.02.078
Sarah Potter BA, Mansara I. Hassan MSN APRN AGNP-C, Laura Tycon Moreines APRN ACHPN, Daniel Weinshenker LMSW MA
Abstract
In this preconference session, attendees will explore the critical importance of wellness in the demanding field of hospice and palliative care by learning to create personalized professional wellness programs. Participants will gain insights into identifying and managing burnout, compassion fatigue, and emotional stress through evidence-based practices and practical strategies. This interactive workshop will guide healthcare professionals in designing a tailored wellness plan that incorporates mindfulness, reflective practices, yoga, and work-life balance techniques to enhance personal well-being and professional effectiveness. By fostering a supportive environment, this session aims to empower attendees with the tools necessary to cultivate resilience, improve patient care, and sustain a fulfilling career in hospice and palliative care.
{"title":"Awaken Your Inner Wellness Warrior","authors":"Sarah Potter BA, Mansara I. Hassan MSN APRN AGNP-C, Laura Tycon Moreines APRN ACHPN, Daniel Weinshenker LMSW MA","doi":"10.1016/j.jpainsymman.2025.02.078","DOIUrl":"10.1016/j.jpainsymman.2025.02.078","url":null,"abstract":"<div><h3>Abstract</h3><div>In this preconference session, attendees will explore the critical importance of wellness in the demanding field of hospice and palliative care by learning to create personalized professional wellness programs. Participants will gain insights into identifying and managing burnout, compassion fatigue, and emotional stress through evidence-based practices and practical strategies. This interactive workshop will guide healthcare professionals in designing a tailored wellness plan that incorporates mindfulness, reflective practices, yoga, and work-life balance techniques to enhance personal well-being and professional effectiveness. By fostering a supportive environment, this session aims to empower attendees with the tools necessary to cultivate resilience, improve patient care, and sustain a fulfilling career in hospice and palliative care.</div></div>","PeriodicalId":16634,"journal":{"name":"Journal of pain and symptom management","volume":"69 5","pages":"Page e459"},"PeriodicalIF":3.2,"publicationDate":"2025-04-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143807051","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-04-10DOI: 10.1016/j.jpainsymman.2025.02.079
Lynn F. Reinke PhD ANP-BC FAAN FPCN, Heather L. Coates PhD APRN-BC FAAN, Judith A. Paice PhD RN, Tracy Fasolino PhD RN FNP-BC ACHP FPCNN, Komal P. Murali PhD RN ACNP-BC, Sarah Potter BA
Abstract
Join us for a dynamic pre-conference session designed specifically for Advanced Practice Registered Nurses (APRNs) looking to enhance their leadership, research, and clinical skills. This interactive session will provide APRNs with valuable insights and tools to elevate their practice through evidence-based treatment, innovative clinical approaches, research initiatives, and effective leadership strategies. Presentations will include case-based scenarios involving pain and symptom management. Attendees will learn how to author successful abstract submissions and the best approach to local and national advocacy. Whether you're looking to sharpen your clinical skills, advance your research capabilities, or strengthen your leadership acumen, this session offers a comprehensive approach to professional growth and excellence in nursing practice.
{"title":"Empowering APRNS in Practice and Leadership","authors":"Lynn F. Reinke PhD ANP-BC FAAN FPCN, Heather L. Coates PhD APRN-BC FAAN, Judith A. Paice PhD RN, Tracy Fasolino PhD RN FNP-BC ACHP FPCNN, Komal P. Murali PhD RN ACNP-BC, Sarah Potter BA","doi":"10.1016/j.jpainsymman.2025.02.079","DOIUrl":"10.1016/j.jpainsymman.2025.02.079","url":null,"abstract":"<div><h3>Abstract</h3><div>Join us for a dynamic pre-conference session designed specifically for Advanced Practice Registered Nurses (APRNs) looking to enhance their leadership, research, and clinical skills. This interactive session will provide APRNs with valuable insights and tools to elevate their practice through evidence-based treatment, innovative clinical approaches, research initiatives, and effective leadership strategies. Presentations will include case-based scenarios involving pain and symptom management. Attendees will learn how to author successful abstract submissions and the best approach to local and national advocacy. Whether you're looking to sharpen your clinical skills, advance your research capabilities, or strengthen your leadership acumen, this session offers a comprehensive approach to professional growth and excellence in nursing practice.</div></div>","PeriodicalId":16634,"journal":{"name":"Journal of pain and symptom management","volume":"69 5","pages":"Page e459"},"PeriodicalIF":3.2,"publicationDate":"2025-04-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143807052","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-04-10DOI: 10.1016/j.jpainsymman.2025.02.085
Mary Lynn McPherson PharmD PhD FAAHPM, Kathryn A. Walker PharmD BCPS FAAHPM
Outcomes
1. Discuss three pearls related to pharmacology of palliative medications.
2. Discuss three pearls related to appropriateness of maintenance medications in EOL care.
We are bringing the Rizz this year with the trendiest medication tips for this year's Speed Dating with the Pharmacy Ladies session. Complex medication decisions are an integral part of treating palliative care patients. Pharmacists have unique expertise to advise clinicians to use medications creatively and effectively. Two pharmacists will speed-date their way through evidence-based medication tips designed to highlight important and practical facts related to drug delivery, dosing, effectiveness and unique aspects of medication use. Objectives include: 1) Discuss 3 pearls related to pharmacology of palliative medications, and 2) Discuss 3 pearls related to appropriateness of maintenance medications in EOL care. Whether debriding a medication profile, aggressively treating symptoms, or strategizing a dosage formulation, we hope that you will find a tip that you are compatible with to spice up your life!
{"title":"Speed Dating With the Pharmacy Ladies","authors":"Mary Lynn McPherson PharmD PhD FAAHPM, Kathryn A. Walker PharmD BCPS FAAHPM","doi":"10.1016/j.jpainsymman.2025.02.085","DOIUrl":"10.1016/j.jpainsymman.2025.02.085","url":null,"abstract":"<div><h3>Outcomes</h3><div>1. Discuss three pearls related to pharmacology of palliative medications.</div><div>2. Discuss three pearls related to appropriateness of maintenance medications in EOL care.</div><div>We are bringing the Rizz this year with the trendiest medication tips for this year's Speed Dating with the Pharmacy Ladies session. Complex medication decisions are an integral part of treating palliative care patients. Pharmacists have unique expertise to advise clinicians to use medications creatively and effectively. Two pharmacists will speed-date their way through evidence-based medication tips designed to highlight important and practical facts related to drug delivery, dosing, effectiveness and unique aspects of medication use. Objectives include: 1) Discuss 3 pearls related to pharmacology of palliative medications, and 2) Discuss 3 pearls related to appropriateness of maintenance medications in EOL care. Whether debriding a medication profile, aggressively treating symptoms, or strategizing a dosage formulation, we hope that you will find a tip that you are compatible with to spice up your life!</div></div>","PeriodicalId":16634,"journal":{"name":"Journal of pain and symptom management","volume":"69 5","pages":"Page e461"},"PeriodicalIF":3.2,"publicationDate":"2025-04-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143807058","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
<div><h3>Outcomes</h3><div>1. Participants will be able to articulate why the limited access to palliative care in rural communities is both a quality and DEI issue.</div><div>2. Participants will be able to describe how collaboration between palliative care champions in rural communities and remote specialized palliative care providers across the range of disciplines, together with experts in program design and development, can enhance access to high quality palliative care for patients and clinicians in rural communities.</div></div><div><h3>Key Message</h3><div>Rural communities wanting to offer palliative care face numerous barriers, creating inequities in access to palliative care for rural residents. This session will highlight an innovative public-private partnership initiated by our state Department of Health, with over 20 additional partner organizations, to develop resources providing access to specialized interdisciplinary palliative care support to 20 participating rural communities.</div></div><div><h3>Abstract</h3><div>Rural communities wanting to offer palliative care (PC) face barriers including a lack of local expertise, clinical training, resources, limited care giving and home health availability, staff turnover, and administrative resistance to funding dedicated PC staff given low volume. Rural residents face geographic barriers accessing services, resources, and opportunities. (1) Within this population, there are wide disparities in health and mortality among socioeconomic groups. (2) Patients in this initiative's rural communities did not have access to palliative care, creating inequities in access to high quality, full spectrum health care.</div></div><div><h3>Objectives</h3><div>This initiative's primary objective is providing individualized support to participating rural communities. Initially, a community engagement strategy brought together diverse organizations in each community. An asset/gap analysis to develop a PC action plan was developed and is annually revisited. Communities targeted objectives such as initiation of clinical screening, launching consultative services, public education, improved coordination, and accessing non-medical supports. Clinical and culture change strategies include skills training, change management, technical assistance, facilitation, gathering of evidence, clinical standard adoption, support for workflow design, an on-line resource portal, and education series. Three cohorts were onboarded over 6 years for a current total of 20 communities. A Learning and Action Network emphasizes peer-to-peer mentoring. Augmenting centralized expertise, teams’ deep knowledge of their own organization(s) and community brings depth and meaning for other participants. In developing local palliative care, we focused on decreasing transfers to distant urban centers by aligning treatment plans with patients’ and families’ goals of care. In a time of competing financial demands on hospital systems, the init
{"title":"A Public-Private Collaborative to Enhance Palliative Care Resources in Rural Communities","authors":"Gregg VandeKieft MD MA, Adrienne Goldberg PhD LICSW, Amber Moody RN CHPN","doi":"10.1016/j.jpainsymman.2025.02.068","DOIUrl":"10.1016/j.jpainsymman.2025.02.068","url":null,"abstract":"<div><h3>Outcomes</h3><div>1. Participants will be able to articulate why the limited access to palliative care in rural communities is both a quality and DEI issue.</div><div>2. Participants will be able to describe how collaboration between palliative care champions in rural communities and remote specialized palliative care providers across the range of disciplines, together with experts in program design and development, can enhance access to high quality palliative care for patients and clinicians in rural communities.</div></div><div><h3>Key Message</h3><div>Rural communities wanting to offer palliative care face numerous barriers, creating inequities in access to palliative care for rural residents. This session will highlight an innovative public-private partnership initiated by our state Department of Health, with over 20 additional partner organizations, to develop resources providing access to specialized interdisciplinary palliative care support to 20 participating rural communities.</div></div><div><h3>Abstract</h3><div>Rural communities wanting to offer palliative care (PC) face barriers including a lack of local expertise, clinical training, resources, limited care giving and home health availability, staff turnover, and administrative resistance to funding dedicated PC staff given low volume. Rural residents face geographic barriers accessing services, resources, and opportunities. (1) Within this population, there are wide disparities in health and mortality among socioeconomic groups. (2) Patients in this initiative's rural communities did not have access to palliative care, creating inequities in access to high quality, full spectrum health care.</div></div><div><h3>Objectives</h3><div>This initiative's primary objective is providing individualized support to participating rural communities. Initially, a community engagement strategy brought together diverse organizations in each community. An asset/gap analysis to develop a PC action plan was developed and is annually revisited. Communities targeted objectives such as initiation of clinical screening, launching consultative services, public education, improved coordination, and accessing non-medical supports. Clinical and culture change strategies include skills training, change management, technical assistance, facilitation, gathering of evidence, clinical standard adoption, support for workflow design, an on-line resource portal, and education series. Three cohorts were onboarded over 6 years for a current total of 20 communities. A Learning and Action Network emphasizes peer-to-peer mentoring. Augmenting centralized expertise, teams’ deep knowledge of their own organization(s) and community brings depth and meaning for other participants. In developing local palliative care, we focused on decreasing transfers to distant urban centers by aligning treatment plans with patients’ and families’ goals of care. In a time of competing financial demands on hospital systems, the init","PeriodicalId":16634,"journal":{"name":"Journal of pain and symptom management","volume":"69 5","pages":"Pages e452-e453"},"PeriodicalIF":3.2,"publicationDate":"2025-04-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143807018","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-04-10DOI: 10.1016/j.jpainsymman.2025.02.073
Tom Gualtieri-Reed MBA, Donna Stevens MHA, Rodney Tucker MD, Perihan El Shanawany MD HEC-C, David Buxton MD FAPA DFAACAP FAAHPM, Heidi Young MD FAAHPM, Randall Schisler MD/MBA, Andrew Esch MD MBA, Kathryn Walker PharmD BCPS FAAHPM, Isabella Park DO
Outcomes
1. Understanding of oneself: Understand and evolve your emotional intelligence for optimal team engagement and performance.
2. Planning: Understand the fundamentals of program development and business planning.
Abstract
This interactive leadership workshop, co-led by AAHPM and CAPC, is designed for emerging and existing leaders to deepen their self-awareness, strengthen their emotional intelligence, and develop essential skills for business planning. Participants will engage in self-assessments, discussions, and exercises that focus on both personal leadership development and the fundamentals of business strategy. This session will guide participants through identifying their leadership goals and understanding their behavioral styles. Using insights from personal assessments, participants will frame a personalized leadership development plan. The workshop will also introduce the core elements of business planning. Participants will work through a planning worksheet to identify a project and explore each section of the business planning process. This workshop encourages participants to take the next steps in their leadership development, equipping them with the tools and insights to lead with emotional intelligence and strategic vision for business planning. Designed for emerging or existing leaders across all settings (acute care, home, clinic, virtual), professions (administration, chaplaincy, medicine, nursing, pharmacy, social work, etc.), and organization types (adult and pediatric acute care, hospice, outpatient, group practice, health plans, etc.),
{"title":"Empower: Elevating Personal Leadership Through Self-Discovery and the Strategic Business Planning","authors":"Tom Gualtieri-Reed MBA, Donna Stevens MHA, Rodney Tucker MD, Perihan El Shanawany MD HEC-C, David Buxton MD FAPA DFAACAP FAAHPM, Heidi Young MD FAAHPM, Randall Schisler MD/MBA, Andrew Esch MD MBA, Kathryn Walker PharmD BCPS FAAHPM, Isabella Park DO","doi":"10.1016/j.jpainsymman.2025.02.073","DOIUrl":"10.1016/j.jpainsymman.2025.02.073","url":null,"abstract":"<div><h3>Outcomes</h3><div>1. Understanding of oneself: Understand and evolve your emotional intelligence for optimal team engagement and performance.</div><div>2. Planning: Understand the fundamentals of program development and business planning.</div></div><div><h3>Abstract</h3><div>This interactive leadership workshop, co-led by AAHPM and CAPC, is designed for emerging and existing leaders to deepen their self-awareness, strengthen their emotional intelligence, and develop essential skills for business planning. Participants will engage in self-assessments, discussions, and exercises that focus on both personal leadership development and the fundamentals of business strategy. This session will guide participants through identifying their leadership goals and understanding their behavioral styles. Using insights from personal assessments, participants will frame a personalized leadership development plan. The workshop will also introduce the core elements of business planning. Participants will work through a planning worksheet to identify a project and explore each section of the business planning process. This workshop encourages participants to take the next steps in their leadership development, equipping them with the tools and insights to lead with emotional intelligence and strategic vision for business planning. Designed for emerging or existing leaders across all settings (acute care, home, clinic, virtual), professions (administration, chaplaincy, medicine, nursing, pharmacy, social work, etc.), and organization types (adult and pediatric acute care, hospice, outpatient, group practice, health plans, etc.),</div></div>","PeriodicalId":16634,"journal":{"name":"Journal of pain and symptom management","volume":"69 5","pages":"Page e456"},"PeriodicalIF":3.2,"publicationDate":"2025-04-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143807230","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-04-10DOI: 10.1016/j.jpainsymman.2025.02.047
Gregg VandeKieft MD MA, Jennifer Ku PharmD BCPS, Juliette Erickson MD, Sue Taylor MSW LICSW ACHP-SW APHSW-C
<div><h3>Outcomes</h3><div>1. Participants will be able to identify ethical challenges in delivery end-of-life care for patient on concurrent immunotherapy.</div><div>2. Participants will be able to describe ways in which different interdisciplinary team members can attempt to address and mitigate moral injury experienced by patients, families, and healthcare teams in ethically challenging situations.</div></div><div><h3>Key Message</h3><div>Patients with metastatic melanoma on palliative immunotherapy face dilemmas at end-of-life that affect symptom management, care options, and risk of moral injury. Interdisciplinary collaboration is key for quality patient care in these situations to ensure patient autonomy and to meet best practices for goal-aligned care and shared decision making.</div></div><div><h3>Abstract</h3><div>Treatment for melanoma has changed since the introduction of immunotherapy in the 1990s. Since then, the median survival rate has improved from 6 months to nearly 6 years for patients with metastatic melanoma. Despite this, the 5-year survival rate remains low at 30% (1). These statistics have led to more patients with metastatic melanoma on immunotherapy at end-of-life (EOL).</div></div><div><h3>Session Format</h3><div>We will use a case-based debate to explore the challenges in honoring patient autonomy, goal-aligned care, and shared decision making for patients on immunotherapy at EOL. Dilemmas include the role of palliative immunotherapy to mitigate rapid disease progression at EOL, symptom management challenges created with concurrent immunotherapy, and the impact of ongoing immunotherapy on hospice eligibility. To highlight challenges involved in EOL care for this unique patient subset, a physician and a pharmacist will explore the following questions for a patient with metastatic melanoma and multiple psychosocial burdens: If immunotherapy is used to mitigate the symptom burden from disease progression but is also rendering analgesics ineffective, should we consider stopping immunotherapy to achieve better symptom control? What should we do if there are no acceptable pain management modalities when the plan is to continue palliative immunotherapy? Can a patient be hospice eligible while continuing palliative immunotherapy? If a patient is not hospice eligible, should we stop immunotherapy to achieve eligibility? What are the ethical implications if stopping immunotherapy accelerates disease progression? How do we address the moral injury clinicians face when navigating these dilemmas? Takeaways: Increased immunotherapy options for patients with metastatic melanoma introduces new and difficult questions for patients, families and healthcare teams at EOL. Our panelists will explore questions that teams may encounter in this patient population. Learners will leave empowered with knowledge and skills to navigate similar challenging conversations as patients approach EOL.</div></div><div><h3>References</h3><div>1. Knight A, K
{"title":"The Hidden Dilemmas of Immunotherapy in Patients With Melanoma at End-of-life","authors":"Gregg VandeKieft MD MA, Jennifer Ku PharmD BCPS, Juliette Erickson MD, Sue Taylor MSW LICSW ACHP-SW APHSW-C","doi":"10.1016/j.jpainsymman.2025.02.047","DOIUrl":"10.1016/j.jpainsymman.2025.02.047","url":null,"abstract":"<div><h3>Outcomes</h3><div>1. Participants will be able to identify ethical challenges in delivery end-of-life care for patient on concurrent immunotherapy.</div><div>2. Participants will be able to describe ways in which different interdisciplinary team members can attempt to address and mitigate moral injury experienced by patients, families, and healthcare teams in ethically challenging situations.</div></div><div><h3>Key Message</h3><div>Patients with metastatic melanoma on palliative immunotherapy face dilemmas at end-of-life that affect symptom management, care options, and risk of moral injury. Interdisciplinary collaboration is key for quality patient care in these situations to ensure patient autonomy and to meet best practices for goal-aligned care and shared decision making.</div></div><div><h3>Abstract</h3><div>Treatment for melanoma has changed since the introduction of immunotherapy in the 1990s. Since then, the median survival rate has improved from 6 months to nearly 6 years for patients with metastatic melanoma. Despite this, the 5-year survival rate remains low at 30% (1). These statistics have led to more patients with metastatic melanoma on immunotherapy at end-of-life (EOL).</div></div><div><h3>Session Format</h3><div>We will use a case-based debate to explore the challenges in honoring patient autonomy, goal-aligned care, and shared decision making for patients on immunotherapy at EOL. Dilemmas include the role of palliative immunotherapy to mitigate rapid disease progression at EOL, symptom management challenges created with concurrent immunotherapy, and the impact of ongoing immunotherapy on hospice eligibility. To highlight challenges involved in EOL care for this unique patient subset, a physician and a pharmacist will explore the following questions for a patient with metastatic melanoma and multiple psychosocial burdens: If immunotherapy is used to mitigate the symptom burden from disease progression but is also rendering analgesics ineffective, should we consider stopping immunotherapy to achieve better symptom control? What should we do if there are no acceptable pain management modalities when the plan is to continue palliative immunotherapy? Can a patient be hospice eligible while continuing palliative immunotherapy? If a patient is not hospice eligible, should we stop immunotherapy to achieve eligibility? What are the ethical implications if stopping immunotherapy accelerates disease progression? How do we address the moral injury clinicians face when navigating these dilemmas? Takeaways: Increased immunotherapy options for patients with metastatic melanoma introduces new and difficult questions for patients, families and healthcare teams at EOL. Our panelists will explore questions that teams may encounter in this patient population. Learners will leave empowered with knowledge and skills to navigate similar challenging conversations as patients approach EOL.</div></div><div><h3>References</h3><div>1. Knight A, K","PeriodicalId":16634,"journal":{"name":"Journal of pain and symptom management","volume":"69 5","pages":"Page e437"},"PeriodicalIF":3.2,"publicationDate":"2025-04-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143807312","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-04-10DOI: 10.1016/j.jpainsymman.2025.02.057
Rachna Goswami MD MPH, Gina Biddle MA BCC-PCHAC, Stacy Sayre LCSW APHSW-C, Joscylene Dracca MSN APRN GNP-BC, Ghewa Sbaiti BS, Eden Mae Rodriguez PharmD, Alexis Barina MD
<div><h3>Outcomes</h3><div>1. Identify and manage common symptoms when patients on heated high flow nasal cannula approach end of life.</div><div>2. Develop strategies to create a culturally competent patient-centered interdisciplinary care plan for patients on heated high flow nasal cannula at end of life.</div></div><div><h3>Key Message</h3><div>Patients who elect to wean heated high flow nasal cannula at end of life often require intensive management of distressing symptoms including dyspnea and anxiety. We will review a stepwise approach to weaning heated high flow nasal cannula at end of life, including symptom management and implementation of culturally competent patient-centered interdisciplinary care plan.</div></div><div><h3>Abstract</h3><div>Heated high flow nasal cannula (HHFNC) allows patients to receive a high level of oxygen support while still being able to remain interactive (1). However, some patients don't recover enough lung function to leave an acute care setting and may elect withdrawal of oxygen support. Best practices for weaning HHFNC and managing symptoms in this setting have not been well studied (2).</div></div><div><h3>Methods</h3><div>We conducted a single-center retrospective chart review on 44 deceased patients who were weaned from HHFNC at a tertiary care medical center. All patients included received care by the inpatient palliative care team between January 2021 and May 2024. The primary objective of this study was to determine the median dosage of opioids and benzodiazepines used during HHFNC wean. Baseline characteristics, maximum HHFNC settings (flow rate and fraction of inspired oxygen) within 48 hours of the wean, opioid and benzodiazepine usage in the two days prior to the wean, time of wean initiation and termination, and cumulative amount of symptom management medications used to prevent and treat escalating dyspnea and anxiety were collected.</div></div><div><h3>Results</h3><div>Patients who elect to wean HHFNC at end-of-life often require intensive management of distressing symptoms including dyspnea and anxiety. We hypothesize that patients who have HHFNC weaned in a stepwise manner experience better symptom control than patients who have HHFNC stopped without a wean. We will share our stepwise approach to weaning HHFNC and the median doses of opioid and benzodiazepine medications used during HHFNC wean.</div></div><div><h3>Conclusion</h3><div>Patients who elect to wean HHFNC at end of life often require intensive management of distressing symptoms. We predict that a stepwise approach to weaning heated high flow nasal cannula and implementation of a culturally competent patient-centered interdisciplinary care plan are fundamental to ensuring high quality care.</div></div><div><h3>References</h3><div>1. Spoletini G, Alotaibi M, Blasi F, Hill NS. Heated humidified high-flow nasal oxygen in adults. Chest. 2015 Jul 1;148(1):253-61. 2. Kim MC, Lee YJ, Park JS, et al. Simultaneous reduction of flow and fract
{"title":"Weaning Heated High Flow Nasal Cannula at End of Life","authors":"Rachna Goswami MD MPH, Gina Biddle MA BCC-PCHAC, Stacy Sayre LCSW APHSW-C, Joscylene Dracca MSN APRN GNP-BC, Ghewa Sbaiti BS, Eden Mae Rodriguez PharmD, Alexis Barina MD","doi":"10.1016/j.jpainsymman.2025.02.057","DOIUrl":"10.1016/j.jpainsymman.2025.02.057","url":null,"abstract":"<div><h3>Outcomes</h3><div>1. Identify and manage common symptoms when patients on heated high flow nasal cannula approach end of life.</div><div>2. Develop strategies to create a culturally competent patient-centered interdisciplinary care plan for patients on heated high flow nasal cannula at end of life.</div></div><div><h3>Key Message</h3><div>Patients who elect to wean heated high flow nasal cannula at end of life often require intensive management of distressing symptoms including dyspnea and anxiety. We will review a stepwise approach to weaning heated high flow nasal cannula at end of life, including symptom management and implementation of culturally competent patient-centered interdisciplinary care plan.</div></div><div><h3>Abstract</h3><div>Heated high flow nasal cannula (HHFNC) allows patients to receive a high level of oxygen support while still being able to remain interactive (1). However, some patients don't recover enough lung function to leave an acute care setting and may elect withdrawal of oxygen support. Best practices for weaning HHFNC and managing symptoms in this setting have not been well studied (2).</div></div><div><h3>Methods</h3><div>We conducted a single-center retrospective chart review on 44 deceased patients who were weaned from HHFNC at a tertiary care medical center. All patients included received care by the inpatient palliative care team between January 2021 and May 2024. The primary objective of this study was to determine the median dosage of opioids and benzodiazepines used during HHFNC wean. Baseline characteristics, maximum HHFNC settings (flow rate and fraction of inspired oxygen) within 48 hours of the wean, opioid and benzodiazepine usage in the two days prior to the wean, time of wean initiation and termination, and cumulative amount of symptom management medications used to prevent and treat escalating dyspnea and anxiety were collected.</div></div><div><h3>Results</h3><div>Patients who elect to wean HHFNC at end-of-life often require intensive management of distressing symptoms including dyspnea and anxiety. We hypothesize that patients who have HHFNC weaned in a stepwise manner experience better symptom control than patients who have HHFNC stopped without a wean. We will share our stepwise approach to weaning HHFNC and the median doses of opioid and benzodiazepine medications used during HHFNC wean.</div></div><div><h3>Conclusion</h3><div>Patients who elect to wean HHFNC at end of life often require intensive management of distressing symptoms. We predict that a stepwise approach to weaning heated high flow nasal cannula and implementation of a culturally competent patient-centered interdisciplinary care plan are fundamental to ensuring high quality care.</div></div><div><h3>References</h3><div>1. Spoletini G, Alotaibi M, Blasi F, Hill NS. Heated humidified high-flow nasal oxygen in adults. Chest. 2015 Jul 1;148(1):253-61. 2. Kim MC, Lee YJ, Park JS, et al. Simultaneous reduction of flow and fract","PeriodicalId":16634,"journal":{"name":"Journal of pain and symptom management","volume":"69 5","pages":"Pages e444-e445"},"PeriodicalIF":3.2,"publicationDate":"2025-04-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143807049","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-04-10DOI: 10.1016/j.jpainsymman.2025.02.087
Stephen Berns MD FAAHPM, Laura Dingfield MD MSEd, Adam Marks MD MPH FAAHPM HEC-C, Corey Tapper MD MS, Carolyn Kezar MD MS FACP, Shireen Heidari MD FAAHPM, Jonathan Yeh MD, Ethan Silverman MD, Toluwalasé Ajayi MD FAAP FAAHPM
Outcomes
1. Describe the work from the AAHHPM Assessment Work Group from the last year.
2. Commit to one-way participants can get involved in improving assessment at their local institution.
Abstract
This preconference workshop is designed to equip fellowship program directors and other interested educators with the tools and knowledge to lead innovative improvements in their training programs. Participants will learn about best practices in fellowship administration and curriculum design, as identified by the Fellowship Training Committee, and will have the chance to share key successes from their own programs. The session will also include a review and discussion of the proposed updates to the ACGME Hospice and Palliative Medicine Program Requirements. Additionally, the AAHPM Assessment Workgroup will present updates on faculty development materials being created in partnership with the ACGME.
{"title":"Best Practices and Beyond: Updates in Fellowship Education","authors":"Stephen Berns MD FAAHPM, Laura Dingfield MD MSEd, Adam Marks MD MPH FAAHPM HEC-C, Corey Tapper MD MS, Carolyn Kezar MD MS FACP, Shireen Heidari MD FAAHPM, Jonathan Yeh MD, Ethan Silverman MD, Toluwalasé Ajayi MD FAAP FAAHPM","doi":"10.1016/j.jpainsymman.2025.02.087","DOIUrl":"10.1016/j.jpainsymman.2025.02.087","url":null,"abstract":"<div><h3>Outcomes</h3><div>1. Describe the work from the AAHHPM Assessment Work Group from the last year.</div><div>2. Commit to one-way participants can get involved in improving assessment at their local institution.</div></div><div><h3>Abstract</h3><div>This preconference workshop is designed to equip fellowship program directors and other interested educators with the tools and knowledge to lead innovative improvements in their training programs. Participants will learn about best practices in fellowship administration and curriculum design, as identified by the Fellowship Training Committee, and will have the chance to share key successes from their own programs. The session will also include a review and discussion of the proposed updates to the ACGME Hospice and Palliative Medicine Program Requirements. Additionally, the AAHPM Assessment Workgroup will present updates on faculty development materials being created in partnership with the ACGME.</div></div>","PeriodicalId":16634,"journal":{"name":"Journal of pain and symptom management","volume":"69 5","pages":"Page e461"},"PeriodicalIF":3.2,"publicationDate":"2025-04-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143807060","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-04-10DOI: 10.1016/j.jpainsymman.2025.02.077
Kate Stackhouse DNP RN FNP-C ACHPN, Cara Dials APRN FNP0C ACHPN
Abstract
This instructor-led certification review course is designed to help prepare you for your upcoming Hospice and Palliative Credentialing Center (HPCC) ACHPN certification exam. HPNA Certification Review Courses provide a framework to prepare, and a process to assess strengths and weaknesses of content prior to sitting for an HPCC certification exam. These courses are facilitated by nationally recognized subject matter experts.
Each module in the review course addresses sections of the detailed content outline from the 2022 HPCC Candidate Handbook. HPCC is not able to conduct or recommend specific review courses. The use of HPNA exam preparation materials does not imply successful performance on HPCC certification exams. The use of HPNA exam preparation materials does not give an advantage over candidates who do not choose to use them.
Continuing Education: Attendees can earn a maximum of 8.75 NCPD hours and 4.0 Category 1 Pharm credits upon successful completion of this course. Successful completion includes attending the activity in its entirety, attesting to attendance, and completing/submitting the postactivity evaluation within the timeframe specified.
The faculty/planners of this accredited continuing professional development activity have disclosed no relevant financial, professional, or personal relationship with ineligible companies pertaining to faculty selection, delivery, and evaluation of this conference. The Hospice and Palliative Nurses Association is an accredited provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation (ANCC). Provider number P0284.
{"title":"ACHPN Certification Review Course","authors":"Kate Stackhouse DNP RN FNP-C ACHPN, Cara Dials APRN FNP0C ACHPN","doi":"10.1016/j.jpainsymman.2025.02.077","DOIUrl":"10.1016/j.jpainsymman.2025.02.077","url":null,"abstract":"<div><h3>Abstract</h3><div>This instructor-led certification review course is designed to help prepare you for your upcoming Hospice and Palliative Credentialing Center (HPCC) ACHPN certification exam. HPNA Certification Review Courses provide a framework to prepare, and a process to assess strengths and weaknesses of content prior to sitting for an HPCC certification exam. These courses are facilitated by nationally recognized subject matter experts.</div><div>Each module in the review course addresses sections of the detailed content outline from the 2022 HPCC Candidate Handbook. HPCC is not able to conduct or recommend specific review courses. The use of HPNA exam preparation materials does not imply successful performance on HPCC certification exams. The use of HPNA exam preparation materials does not give an advantage over candidates who do not choose to use them.</div><div>Continuing Education: Attendees can earn a maximum of 8.75 NCPD hours and 4.0 Category 1 Pharm credits upon successful completion of this course. Successful completion includes attending the activity in its entirety, attesting to attendance, and completing/submitting the postactivity evaluation within the timeframe specified.</div><div>The faculty/planners of this accredited continuing professional development activity have disclosed no relevant financial, professional, or personal relationship with ineligible companies pertaining to faculty selection, delivery, and evaluation of this conference. The Hospice and Palliative Nurses Association is an accredited provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation (ANCC). Provider number P0284.</div></div>","PeriodicalId":16634,"journal":{"name":"Journal of pain and symptom management","volume":"69 5","pages":"Pages e458-e459"},"PeriodicalIF":3.2,"publicationDate":"2025-04-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143807068","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}